PCVX Award Disclosure
Jodar Luis · SEC Form 4 · Filed Sep 9, 2026
Award
Calculated transaction value
$0
Jodar Luis Chief Medical Officer
PCVX
Vaxcyte
PCVX
Transaction date
Sep 4, 2026
Public filing date
Sep 9, 2026
Filing lag
Filed 5 days later
PCVX daily price context
Close on/before transaction
$61.16
Sep 4, 2026
Close before public filing
$60.36
Sep 8, 2026
Return since public filing
-3.69%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 52,632 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0002151661-26-000004
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Vaxcyte, Inc. PCVX Current | Award | Sep 4, 2026 | $0 |
| Vaxcyte, Inc. PCVX | Award | Sep 4, 2026 | $0 |